Valganciclovir

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Valganciclovir and local guidelines before prescribing.

Antiviral (CMV)

Mechanism

Prodrug of ganciclovir inhibiting CMV DNA polymerase.

Uses

CMV infection and prophylaxis in transplant recipients, CMV retinitis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Neutropenia, anaemia, thrombocytopenia, nausea, diarrhoea, teratogenicity.

Interactions

Mycophenolate and other myelosuppressants; imipenem seizures.

Contraindications and cautions

Neutropenia below 0.5, thrombocytopenia

Monitoring

FBC, U&E

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce dose with eGFR

Overdose and reversal

Supportive

Special advice

FBC twice weekly early; handle tablets carefully.

More from the textbook: uses, cautions and other points
Where it is discussed in the book